Skip to content

Risk Assessment and CCS for Sterility Testing

January 2025

Author:

Dr. Timo Krebsbach

SKAN

Scientific paper

PDF

Download here

About the paper

This paper focuses on the role of sterility testing in the release of aseptically manufactured medicinal products and its integration into a Contamination Control Strategy (CCS). It outlines how risk assessment can be used as a scientifically sound and practical approach to identify critical control points and ensure compliance with Annex 1 of the EU-GMP-guidelines.

Why the topic matters

Sterility testing is a critical step in ensuring the safety and efficacy of aseptically produced medicinal products before they are released to the market. Regulatory requirements demand that this testing be fully integrated into a comprehensive contamination control strategy. A structured risk assessment approach helps identify and control potential contamination risks, ensuring both compliance and product safety while enabling continuous process improvement.

Get free access to our scientific paper!

*required

Back to top